Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver diseaseZoe Boyer‐Díaz, Jordi Gracia‐Sancho, Martí Ortega‐Ribera et al.|Journal of Hepatology|2020Cited by 163
A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver DiseaseZoe Boyer‐Díaz, Jordi Gracia‐Sancho, Joan Carles Domingo et al.|Nutrients|2019Cited by 22
A Novel Multi-organ Male Model of Alcohol-induced Acute-on-chronic Liver Failure Reveals NET-mediated Hepatocellular Death, Which is Prevented by RIPK3 InhibitionMartí Ortega‐Ribera, Gyöngyi Szabó|Cellular and Molecular Gastroenterology and Hepatology|2024Cited by 13
G-CSF increases calprotectin expression, liver damage and neuroinflammation in a murine model of alcohol-induced ACLFMartí Ortega‐Ribera, Gyöngyi Szabó|Frontiers in Cell and Developmental Biology|2024Cited by 10
Gasdermin D deletion prevents liver injury and exacerbates extrahepatic damage in a murine model of alcohol-induced ACLFMartí Ortega‐Ribera, Gyöngyi Szabó|eGastroenterology|2025Cited by 4